Specifically, phosphorylation at serine residues 25 (ser25) and 38 (ser38) of STMN1 was shown to be increased in cells with higher metastatic potential and was also associated with increased morbidity and mortality in breast cancer patients. This evidence concerns the gene STMN1 and breast cancer.